A revised version of the American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer provides an important review of current data on therapeutic modalities and offers improved clinical strategies for the optimal management of these thyroid pathologies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cooper, D. S. et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16, 109–142 (2006).
Cooper, D. S. et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167–1214 (2009).
Puxeddu, E. & Filetti, S. The 2009 American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: progress on the road from consensus- to evidence-based practice. Thyroid 19, 1145–1147 (2009).
British Thyroid Association & Royal College of Physicians. Guidelines for the Management of Thyroid Cancer (ed. P. Perros) 2nd edition [online], (2007).
Hartl, D. M. & Travagli, J. P. The updated American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: a surgical perspective. Thyroid 19, 1149–1151 (2009).
Mazzaferri, E. L., Doherty, G. M. & Steward, D. L. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19, 683–689 (2009).
White, M. L., Gauger, P. G. & Doherty, G. M. Central lymph node dissection in differentiated thyroid cancer. World J. Surg. 31, 895–904 (2007).
Sosa, J. A. et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann. Surg. 228, 320–330 (1998).
Gupta-Abramson, V. et al. Phase II trial of sorafenib in advanced thyroid cancer. J. Clin. Oncol. 26, 4714–4719 (2008).
Sherman, S. I. et al. Motesanib diphosphate in progressive differentiated thyroid cancer. N. Engl. J. Med. 359, 31–42 (2008).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Boelaert, K. Revised guidelines for the management of thyroid cancer. Nat Rev Endocrinol 6, 185–186 (2010). https://doi.org/10.1038/nrendo.2010.17
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2010.17
This article is cited by
-
Does 131I Radioactivity Interfere with Thyroglobulin Measurement in Patients Undergoing Radioactive Iodine Therapy with Recombinant Human TSH?
Nuclear Medicine and Molecular Imaging (2015)
-
Expression and clinical significance of STIP1 in papillary thyroid carcinoma
Tumor Biology (2014)
